Free Newsletter
SAE report triggers calls for FDA reform
In the wake of yesterday's news about adverse events, the FDA is getting a splash of cold water to the face. The Archives of Internal Medicine report showed a doubling of serious side effects, including death, from 1998 to 2005--and now, there's an outcry for reform.
But what to do? Congress is asking for money so the FDA can hire more scientists and drug-safety experts. Politicians also are calling on the agency to act on the adverse event data already collected. Meanwhile, the agency suggests that side effects may not have increased, just reporting of side effects. And the debate rages on.
- read the article from the Chicago Tribune
Related Articles:
Adverse drug events, deaths soar. Report
Poll finds problems at the FDA. Report
FDA offers safety reforms to skeptical lawmakers. Report
IOM slams FDA, calls for major reforms. Report
Pharmacovigilance grows in importance. Report
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession






SHARE
WITH: